Related by context. All words. (Click for frequent words.) 71 antitumor 71 chemopreventive 70 anti angiogenic 69 potent anticancer 67 neuroprotective 66 immunomodulatory 65 anti proliferative 65 antiviral 65 cytotoxic 64 anticancer agents 64 inhibit tumor 63 antitumor effect 63 anticancer therapy 63 immunomodulator 62 antitumoral 62 immune stimulatory 62 gene silencing 62 taxanes 62 anticancer agent 62 anticancer drugs 62 chemotherapeutic agents 61 molecularly targeted 61 chemotherapeutic drug 61 antiangiogenic 61 interferons 61 insulin sensitizing 61 anticancer activity 61 chemopreventive agent 61 proteasome inhibitor 61 immune modulatory 61 antitumour 61 chemotherapeutic agent 61 proteasome inhibitors 61 immunosuppressive 61 taxol 61 selective inhibition 61 neuro protective 61 anti inflammatory 60 chemotherapeutic 60 neuroprotective properties 60 anti leukemic 60 enzyme inhibitor 60 chemotherapeutics 60 GRN#L 60 antisense 60 Panzem 60 oral antiviral 60 microtubule targeting 60 multitargeted 60 PXD# 60 potent antiviral 60 flavopiridol 60 Zolinza 60 immunomodulating 59 PARP inhibitors 59 chemotherapeutic drugs 59 cilengitide 59 histone deacetylase inhibitors 59 immune modulator 59 paclitaxel Taxol 59 novel anticancer 59 pro apoptotic 59 Hedgehog pathway 59 Tarvacin 59 curcumin 59 immune modulating 59 tyrosine kinase inhibitor 59 hedgehog pathway 59 vascular disrupting agent 59 antithrombotic 59 milatuzumab 59 SERMs 59 potent antioxidant 59 antiinflammatory 59 Hsp# inhibitors 59 ixabepilone 59 amrubicin 59 PI3K inhibitor 59 antiproliferative 59 HDAC 59 PLX# 59 retinoid 59 Cisplatin 59 Gefitinib 59 Hedgehog signaling pathway 59 HSP# inhibitor 59 cytoprotective 59 antitumor activity 58 anti amnesic 58 RNA silencing 58 potent antibacterial 58 PARP inhibitor 58 MEK inhibitors 58 antitumor effects 58 erlotinib Tarceva 58 alkylating agent 58 HDAC inhibitors 58 #ME# 58 potent neuroprotective 58 orally bioavailable 58 OXi# 58 mTOR inhibitors 58 pharmacological 58 angiogenesis inhibitors 58 antioxidant 58 deacetylase inhibitors 58 CYC# 58 MAXY G# 58 tubulin binding 58 CBLC# 58 immunotoxins 58 immunotherapy 58 vascular disrupting 58 enzyme inhibitors 58 cholesterol lowering 58 antiangiogenesis 58 HCV protease 58 obatoclax 58 small molecule 58 Preclinical studies 58 vinblastine 58 IAP inhibitors 58 neurotrophic 58 peptide antigens 58 vorinostat 58 alpha interferon 58 bortezomib 58 integrase inhibitor 58 ganetespib 58 BMS # 57 immunostimulatory 57 interferon beta 57 anti angiogenic agent 57 pomalidomide 57 Sphingomab 57 antidiabetic 57 polymerase inhibitors 57 radioprotective 57 angiogenesis inhibitor 57 anti angiogenesis 57 triterpenoids 57 DepoVax 57 anti neoplastic 57 Sulforaphane 57 selectively inhibit 57 PEG SN# 57 PI3K inhibitors 57 Symadex 57 EGF receptor 57 cannabinoid 57 eniluracil 57 antiviral activity 57 ENMD # 57 tranilast 57 VEGF receptor 57 AKT inhibitor 57 NFkappaB 57 monoclonal antibody 57 kinase inhibitors 57 potentiator 57 Preclinical studies suggest 57 antibody 57 Onconase 57 HIV protease inhibitors 57 AP# [003] 57 sulforaphane 57 Carfilzomib 57 receptor inhibitor 57 AMN# [001] 57 immuno modulatory 57 anticancer therapies 57 trastuzumab Herceptin 57 Crizotinib 57 antifungal 57 siRNA therapeutics 57 Erbitux cetuximab 57 histone deacetylase inhibitor 57 Genentech Herceptin 57 bendamustine 57 epothilones 57 Hsp# inhibitor 57 inhibit angiogenesis 57 OMP #M# 57 imatinib Gleevec ® 57 selective inhibitor 57 chemoprotective 57 resolvins 57 Cotara 57 preclinically 57 intranasal delivery 57 immune modulation 57 DFMO 57 bortezomib Velcade 56 xenograft models 56 anti atherogenic 56 orally dosed 56 peroxisome proliferator activated 56 vascular disrupting agents 56 oral prodrug 56 GM CSF 56 cancer immunotherapy 56 Tyrima 56 seliciclib 56 cytostatic 56 protease inhibitors 56 chemoprevention 56 YONDELIS 56 Interferon alpha 56 kinase inhibitor 56 Vidofludimus 56 gamma secretase inhibitor 56 BAL# [001] 56 chronic lymphocytic leukemia CLL 56 oncolytic 56 Imprime PGG 56 potent antiproliferative 56 sulindac 56 lapatinib Tykerb 56 immunotoxin 56 fumagillin 56 Cytoxan 56 sorafenib Nexavar 56 monoclonal antibodies 56 incretin 56 imatinib Gleevec 56 synthetic peptide 56 decitabine 56 humanized antibody 56 anticancer compounds 56 Aurora kinase 56 trabectedin 56 JAK3 56 immunotherapeutic 56 cytotoxicity 56 biologic therapeutics 56 antineoplastic 56 epothilone 56 PCK# 56 itraconazole 56 Bortezomib 56 pro angiogenic 56 novel peptide 56 Squalamine 56 antisense drug 56 Rasagiline 56 naringenin 56 rapamycin 56 Gleevec resistant 56 cardioprotective effects 56 tesetaxel 56 IAP inhibitor 56 elvitegravir 56 forskolin 56 antigen sparing 56 Xanafide 56 Pertuzumab 56 CDK inhibitors 56 chimeric monoclonal antibody 56 relapsed ovarian cancer 56 tyrosine kinase inhibitors 56 BRAF inhibitor 56 huperzine 56 liposomal formulation 56 RDEA# 56 NEUGENE 56 erythropoietic 56 alvespimycin 56 mertansine 56 IMGN# 56 EGFr 56 TLR9 agonist 56 anti angiogenic drugs 56 protein kinase inhibitor 55 apoptosis inducing 55 immunomodulatory effects 55 targeting CD# 55 OHR/AVR# 55 Vorinostat 55 BNC# 55 Nanobody ® 55 immune modulators 55 olaparib 55 FGFR 55 cancer immunotherapies 55 Curcumin 55 therapeutic monoclonal antibody 55 tipifarnib 55 preclinical studies 55 chemopreventive agents 55 Irinotecan 55 anti secretory 55 Elvitegravir 55 selective inhibitors 55 antiproliferative effects 55 immune suppressive 55 enzastaurin 55 MGCD# [001] 55 neurotoxicity 55 oral anticancer 55 anticancer therapeutics 55 coenzyme Q# 55 pertuzumab 55 inhibitory effects 55 HCV protease inhibitors 55 histone deacetylase HDAC inhibitor 55 Abiraterone acetate 55 voreloxin 55 polyketides 55 potent anti angiogenic 55 active metabolite 55 JAK inhibitors 55 Apo2L 55 EGFR pathway 55 Virulizin ® 55 ASONEP 55 XmAb# 55 histone deacetylase HDAC 55 angiogenesis inhibition 55 Pterostilbene 55 Cloretazine R 55 TLR8 55 blood clot dissolving 55 RGB # 55 multi kinase inhibitor 55 retinoids 55 CTLA 4 55 potent inhibitor 55 Alpharadin 55 potent cytotoxic 55 BiTE 55 EphA2 55 receptor agonists 55 Nanobody 55 vaccine adjuvant 55 siRNA 55 thalidomide Thalomid 55 CA4P 55 microtubule inhibitor 55 GAP #B# 55 sirtuin 55 poly ADP ribose polymerase 55 cardio protective 55 targeted antifolate 55 CD# monoclonal antibody 55 detoxification enzymes 55 epigallocatechin gallate EGCG 55 solithromycin 55 gemcitabine 55 antiangiogenic activity 55 echinocandins 55 Dasatinib 55 pleiotropic 55 Ceflatonin 55 anti tumoral 55 elesclomol 55 perifosine 55 HDACi 55 antimetastatic 55 mapatumumab 55 Epothilones 55 bioactive 55 interferon IFN 55 immunomodulatory properties 55 Debio 55 inhibiting tumor 55 phosphatidylserine 55 novel immunomodulatory 55 TriRima 55 calcitriol 55 therapeutic 55 molecularly targeted therapy 55 immunosuppressant 55 interferon 55 SRT# [003] 55 humanized monoclonal antibodies 55 favorable pharmacokinetic profile 55 Perifosine 55 talabostat 55 pharmacologically active 55 IGF 1R 55 nucleoside analogs 55 adjuvant 55 metaglidasen 55 Lodamin 55 TREANDA 55 Erlotinib 55 HDAC inhibition 55 gamma secretase inhibitors 55 histone deacetylases 55 raltegravir 55 antiobesity 55 JAK inhibitor 55 anti VEGF 55 Sorafenib 55 torezolid phosphate 55 endostatin 55 factor TNF 55 TLR9 agonists 55 LY# [003] 55 BAY #-# 55 chemotherapies 55 indibulin 55 INGN 55 MEK inhibitor 55 SAR# [004] 55 tumorigenic 55 small molecule inhibitors 55 DACH platinum 55 hypoxia inducible factor 55 Atiprimod 55 HuLuc# 55 EGFR inhibitors 55 ellagic acid 55 thrombopoietin 55 VEGF inhibitors 55 antifibrotic 55 EGCG 55 recombinant antibodies 55 PDE4 inhibitor 55 bioactive compounds 55 tumor vascular disrupting 54 pharmacokinetic interactions 54 PSMA ADC 54 geldanamycin 54 exon skipping 54 Th1 type 54 amifostine 54 nanoparticle formulation 54 AEG# 54 GSK3 54 Taxotere docetaxel 54 nucleoside analogues 54 estrogenic 54 therapeutic monoclonal antibodies 54 Thiovir 54 temozolomide 54 DXL# 54 brostallicin 54 pan HDAC inhibitor 54 anticancer compound 54 protease inhibitor 54 torezolid 54 bavituximab 54 anti oxidant 54 erlotinib 54 TNFa 54 IMA# 54 CDDO Im 54 selective modulator 54 bevacizumab Avastin 54 monoclonal antibody therapies 54 ubiquinone 54 anticlotting 54 OncoVEX 54 Doxorubicin 54 berberine 54 gemcitabine Gemzar 54 MMP inhibitors 54 CD# antibody [001] 54 CCX# 54 prodrug 54 antiviral compounds 54 Tß4 54 NXL# 54 CCR2 54 cisplatin 54 pharmacologic 54 #I TM# 54 Nasdaq IMGN biotechnology 54 lupus nephritis 54 gamma secretase 54 vinca alkaloid 54 etoposide 54 cyclosporin 54 A3 adenosine receptor 54 SCH # 54 disease modifying 54 Darinaparsin 54 Tarvacin TM 54 Anidulafungin 54 davunetide 54 proteasome inhibitor bortezomib 54 MUC1 54 antiapoptotic 54 Iressa gefitinib 54 parthenolide 54 Pemetrexed 54 Curaxin 54 HCV protease inhibitor 54 CORT # 54 genotoxic 54 cannabinoids 54 adecatumumab 54 Blinatumomab 54 polymerase inhibitor 54 bifunctional 54 tkRNAi 54 radiolabeled monoclonal antibody 54 Vaxfectin 54 interferon lambda 54 sorafenib 54 SIRT2 54 BZL# 54 NF kB pathway 54 lipid lowering 54 acetylcholinesterase 54 apigenin 54 potently inhibit 54 PKCi 54 Dapagliflozin 54 antisense oligonucleotide 54 CXCR4 receptor 54 cyclopamine 54 RANK ligand 54 anti CD3 54 anti EGFR antibody 54 Sym# 54 hematological cancers 54 Pathway Inhibitor 54 HCV replication 54 N acetylcysteine 54 alkylating 54 inhibits protein synthesis 54 tumor antigen 54 peroxidase 54 virotherapy 54 anti fibrotic 54 erlotinib Tarceva ® 54 molecule 54 muscarinic 54 LY# [002] 54 OncoVEX GM CSF 54 docetaxel Taxotere 54 PKM2 54 humanised monoclonal antibody 54 DHFR 54 IVIg 54 induces apoptosis 54 carfilzomib 54 selective kinase inhibitor 54 oritavancin 54 dasatinib 54 imetelstat 54 IFN alpha 54 pharmacokinetic properties 54 CYT# 54 telomerase inhibitor 54 HER2 receptor 54 bactericidal 54 tremelimumab 54 anti androgen 54 abiraterone 54 radiotherapeutic 54 Valproic acid 54 Zybrestat 54 radiolabeled 54 c MYC 54 nucleoside 54 TLR agonists 54 favorable pharmacokinetic 54 Gemcitabine 54 tocotrienols 54 depsipeptide 54 T DM1 54 prokinetic 54 mimetics 54 oxidative stress inducer 54 receptor antagonists 54 immunomodulation 54 induce apoptosis 54 gefitinib Iressa 54 viral kinetics 54 Homspera 54 DsiRNA 54 pharmacodynamic 54 kinase inhibition 54 neuroprotectant 54 Panzem NCD 53 redox active 53 BRAF inhibitors 53 anti CD3 antibody 53 EGFR tyrosine kinase inhibitors 53 superoxide dismutase 53 antioxidative 53 idarubicin 53 Anti Tumor 53 DepoVax TM 53 nanoparticle 53 inhibit viral replication 53 cholinesterase inhibitors 53 nanocarriers 53 rituximab Rituxan 53 BRAF kinase 53 pegylated liposomal doxorubicin 53 I3C 53 HGS ETR1 53 Interferon beta 53 Ontak 53 PI3K 53 photoprotective 53 cytotoxic agents 53 immune suppressing 53 Pazopanib 53 VEGF inhibitor 53 neuroprotective effects 53 melanoma tumors 53 Enzastaurin 53 Smac mimetic 53 signal transduction inhibitor 53 lapatinib 53 receptor tyrosine kinase inhibitor 53 humanized anti 53 PGE2 53 nucleoside analog 53 S/GSK# 53 nanomolar range 53 polyphenolic compounds 53 act synergistically 53 pterostilbene 53 immunotherapeutics 53 inhibited tumor 53 glutathione peroxidase 53 Viprovex 53 peptides 53 soy isoflavones 53 Sirtuins 53 glucose lowering 53 targeted radiotherapeutic 53 TAT2 53 MAb 53 bleomycin 53 anthrax toxin 53 cediranib 53 ellagitannins 53 Angiocept 53 HQK 53 ISIS # 53 Everolimus 53 EGFR 53 nanocarrier 53 estramustine 53 insulin sensitizers 53 axitinib 53 biodistribution 53 LPA1 53 lorvotuzumab mertansine 53 PI3K Akt 53 HuMax CD4 53 REP# 53 liposome encapsulated 53 Factor VIIa 53 bioactive lipids 53 HGS# 53 inhibitory effect 53 HSP# inhibitors 53 antifungal drugs 53 MGd 53 Cloretazine 53 antisense inhibitor 53 oncolytic viruses 53 Trastuzumab 53 neuraminidase inhibitor 53 BanLec 53 PARP inhibition 53 recombinant erythropoietin 53 demethylating agents 53 rituximab 53 nitazoxanide 53 Valortim R 53 immunoregulatory 53 Smac mimetics 53 interleukins 53 Nicotinamide 53 tafamidis 53 BN# [002] 53 sapacitabine 53 EndoTAGTM 1 53 CYT# potent vascular disrupting 53 bevacizumab Avastin ® 53 AAG geldanamycin analog 53 pharmacodynamic properties 53 investigational hepatitis C 53 UsiRNAs 53 inhibit enzymes 53 Liposomal 53 PEGylated 53 neuroprotection 53 TRV# [001] 53 antioxidant enzymes 53 antisense compounds 53 TG# [003] 53 anticancer treatments 53 dasatinib Sprycel 53 Vidaza azacitidine 53 Quercetin 53 effector function 53 mAbs 53 doxorubicin 53 IgG1 antibody 53 TLR9 53 induce tumor regression 53 inhibit EGFR 53 siRNAs 53 Talabostat 53 Archexin 53 NexACT 53 epigallocatechin gallate 53 investigational compound 53 Homspera TM 53 Atrasentan 53 inhibit metastasis 53 liposomal 53 cancer chemoprevention 53 antibacterial 53 Aurora kinase inhibitors 53 CB2 receptor 53 JVRS 53 Taxol paclitaxel 53 sunitinib Sutent ® 53 HuMax CD# 53 Elacytarabine 53 Rapamycin 53 solid tumors 53 topical lotion 53 CCR5 inhibitor 53 thymalfasin 53 flavonoids 53 Schisandrin B 53 CB1 antagonists 53 perampanel 53 estrogen receptor beta 53 DAVANAT R 53 macrolide antibiotics 53 endothelin receptor antagonists 53 dexpramipexole 53 TLR7 53 Golimumab 53 mTOR inhibitor 53 echinocandin 53 gastrin 53 CGEN # 53 Rituxan rituximab 53 cytotoxic T 53 anti oxidant properties 53 investigational humanized monoclonal antibody 53 immunotherapies 53 prodrugs 53 EGFR HER 53 tumor suppressor 53 Hycamtin 53 multikinase inhibitor 53 IMC A# 53 MORAb 53 drug metabolizing enzyme 53 HDAC inhibitor 53 GMX# 53 neurotrophic factors 53 potent inhibitors 53 therapeutic peptide 53 histone deacetylase HDAC inhibitors 53 ipilimumab 53 Neugene 53 androgen receptor 53 superficial bladder cancer 53 Valortim ® 53 BioVant 53 cetuximab Erbitux 53 oral JAK1 53 delafloxacin 53 azoles 53 Abiraterone 53 anti angiogenic agents 53 ON #.Na 53 Avastin bevacizumab 53 bioavailability 53 mAb 53 small molecule defensin 53 p# MAP kinase inhibitor 53 RNAi therapeutic 53 p# inhibitors 53 promising anticancer 53 anti anginal 53 antiviral antibacterial 53 GSK3B 53 TRAIL induced apoptosis 53 Antiangiogenic 53 defensins 53 potent antitumor 53 Posiphen 53 cytotoxics 53 antibody fragment 53 carbohydrate polymer 53 fulvestrant 53 preclinical 53 novel peptides 53 activin 53 REOLYSIN ® 52 inhibiting telomerase 52 monoclonal 52 small molecule tyrosine 52 Abl 52 chelator 52 heparanase 52 inhibits tumor 52 Azixa 52 TNFα 52 taxane 52 peptibody 52 JAK2 inhibitor 52 mimetic compounds 52 Olaparib 52 leucovorin 52 fibrinolytic 52 Taxol ® 52 dendrimer 52 CDK inhibitor 52 Hsp# inhibition 52 epigenetic therapies 52 LEX System 52 cyclooxygenase 52 panobinostat 52 CBLB# 52 NPD1 52 ISF# 52 Sirtuin 52 Tesetaxel 52 panitumumab Vectibix 52 mTOR mammalian target 52 olmesartan 52 nanoviricide 52 biologic 52 Angiolix 52 mitochondrial toxicity 52 Romidepsin 52 anti CD# antibody 52 Neulasta ® 52 pazopanib 52 Protease inhibitors 52 thiazolides 52 velafermin 52 RNAi 52 antagomirs 52 Maribavir 52 Omacetaxine 52 generation Hsp# inhibitor 52 protein kinases 52 Talactoferrin 52 PI3K/Akt pathway inhibitor 52 vitro studies 52 systemic antifungal 52 docetaxel chemotherapy 52 urate lowering 52 immunological 52 sphingosine 1 52 renoprotective 52 asparaginase 52 antitumor efficacy 52 tanespimycin 52 neuraminidase inhibitors 52 immunosuppressant drug 52 Aplidin 52 nab paclitaxel 52 IDH1 52 ligand TRAIL 52 mecamylamine 52 cruciferous vegetables 52 TB4 52 PKC# 52 humanized monoclonal antibody 52 pegylated 52 γ secretase 52 infliximab Remicade 52 Daclizumab 52 CCR1 52 Cyclosporin 52 sodium glucose cotransporter 52 Lapatinib 52 siRNA therapeutic 52 thrombin receptor 52 Enkephalin 52 Annamycin 52 cannabinoid receptor 52 Th# 52 lipoic acid 52 topoisomerase 52 Serdaxin 52 Paclitaxel 52 pharmacokinetics pharmacodynamics 52 piperine 52 Cyclin E 52 selective antagonist 52 p#/CBP 52 VEGFb 52 SIRT1 activation 52 immunomodulators 52 neratinib 52 inhibitory activity 52 CXB# 52 VA# [002] 52 personalized immunotherapy 52 highly selective inhibitor 52 siRNA delivery 52 ASC J9 52 ubiquitin ligases 52 glucagon receptor 52 Aurora kinase inhibitor 52 CK2 52 Antiviral 52 macrolide 52 Voreloxin 52 anticarcinogenic 52 NeuroVax TM 52 Polyphenon E 52 Ii protein 52 hepatotoxic 52 trastuzumab Herceptin ® 52 synthetic peptides 52 aptamers 52 hematologic malignancies 52 androgen receptor AR 52 vismodegib 52 PI3 kinase inhibitors 52 orally administered inhibitor 52 triptolide 52 bevirimat 52 PI3 kinase 52 NexACT ® 52 aptamer 52 antimicrobial compounds 52 cetuximab 52 Doxil ® 52 PSN# [002] 52 viral proteins 52 miR #a [002] 52 Muraglitazar 52 Amplimexon 52 selectively inhibits 52 angiotensin receptor blocker ARB 52 uric acid lowering 52 Pralatrexate 52 cyclin dependent kinase inhibitor 52 radiolabeled TM# 52 ErbB3 52 receptor agonist 52 radical scavenging 52 Neuvenge 52 FOLFOX chemotherapy 52 nanomolar 52 mGluR5 antagonist 52 JAK kinases 52 cardioprotective 52 riociguat 52 Anacetrapib 52 reversible inhibitor 52 Targretin 52 CD# antibodies 52 BioSilicon 52 mda 7 52 Pimavanserin 52 selective estrogen receptor 52 acadesine 52 intravenously administered 52 Temozolomide 52 Panzem R NCD 52 beta lactams 52 IFNs 52 fosbretabulin 52 Sphingosine 1 52 phase IIb clinical 52 Aptivus ® 52 preclinical efficacy 52 AMPK activators 52 renin inhibitors 52 EndoTAG 52 HMG CoA reductase inhibitors 52 protein tyrosine phosphatase 1B 52 TRAIL receptor antibodies 52 beta lactam antibiotics 52 MAGE A3 ASCI 52 Zysolin TM 52 direct thrombin inhibitors 52 potency selectivity 52 optimized siRNA 52 Calcitonin 52 colon carcinoma 52 synthetic retinoid 52 glucocorticoid receptor 52 TLR8 agonist 52 Omacetaxine mepesuccinate 52 silymarin 52 antioxidant properties 52 recurrent ovarian cancer 52 atacicept 52 triglyceride lowering 52 Apoptone 52 anthracycline chemotherapy 52 farletuzumab 52 factor G CSF 52 Litx